Puma Biotech (PBYI) Tops Q1 EPS by 17c

Puma Biotech (NASDAQ: PBYI) reported Q1 EPS of $0.09, $0.17 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $52.8 million versus the consensus estimate of $51 million.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Change in Nonfarm Payrolls (Aug) 162K vs 55K Expected, Unemployment Rate 4.1%
• UBS Reiterates Buy Rating on PVH Corp (PVH) on Strong Earnings Growth Potential